Literature DB >> 26666421

Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions.

Jérôme Doyen1,2,3, Valérie Duranton-Tanneur4,5, Isabelle Hostein6, Marie Karanian-Philippe6,7,8, Christine Chevreau9, Florence Breibach10, Michael Coutts11,12, Bérengère Dadone4,5,11, Marie-Christine Saint-Paul11, Jean Gugenheim13, Florence Duffaud14, Florence Pedeutour4,5.   

Abstract

Desmoid type fibromatosis (DT) is a rare lesion of unclear pathogenesis that most often presents a mutation of the (β-catenin) gene. The natural history and clinical evolution are highly variable between patients and to date there is no consensus on optimal therapy. We report two cases of a patient with multiple DT lesions. Molecular investigations performed in both patients on multiple tumors at different anatomical sites revealed non-identical CTNNB1 mutations. The first patient was a 39-year-old man with a history of recurrent DT. In two of the DT lesions, three different mutations were found in codons 41 and 45, respectively. The lesions showed marked inflammatory features, characterized by IgG4 positive lymphoplasmacytic infiltrates and a foreign body reaction, which increased in intensity over time. The patient was eventually treated with a COX-2 inhibitor and the remaining mass was stabilized. In the two DT lesions of the second patient, CTNNB1 mutations S45P and T41A were found. The presence of different mutations in multiple focally recurrent sporadic DT lesions indicates that they do not have a clonal relationship. Our data suggest that a CTNNB1 mutation is a necessary event probably by providing a selective growth advantage. An IgG4 host antigen response is discussed as a potential predisposing factor for one of the patients.

Entities:  

Keywords:  Desmoid tumor; IgG4; Mesenteric tumor; Sporadic mutation; β-Catenin

Mesh:

Substances:

Year:  2015        PMID: 26666421     DOI: 10.1007/s00428-015-1883-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry.

Authors:  Mikael Ebbo; Laurent Daniel; Michel Pavic; Pascal Sève; Mohamed Hamidou; Emmanuel Andres; Stéphane Burtey; Laurent Chiche; Jacques Serratrice; Maïté Longy-Boursier; Marc Ruivard; Julien Haroche; Bertrand Godeau; Anne-Bérengère Beucher; Jean-Marie Berthelot; Thomas Papo; Jean-Loup Pennaforte; Audrey Benyamine; Noémie Jourde; Cédric Landron; Pascal Roblot; Olivier Moranne; Christine Silvain; Brigitte Granel; Fanny Bernard; Veronique Veit; Karin Mazodier; Emmanuelle Bernit; Hugues Rousset; José Boucraut; Jean-Jacques Boffa; Pierre-Jean Weiller; Gilles Kaplanski; Pierre Aucouturier; Jean-Robert Harlé; Nicolas Schleinitz
Journal:  Medicine (Baltimore)       Date:  2012-01       Impact factor: 1.889

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.

Authors:  Sébastien Salas; Frederic Chibon; Tetsuro Noguchi; Philippe Terrier; Dominique Ranchere-Vince; Pauline Lagarde; Jean Benard; Sébastien Forget; Camille Blanchard; Julien Dômont; Sylvie Bonvalot; Louis Guillou; Agnès Leroux; Agnes Mechine-Neuville; Patrick Schöffski; Marik Laë; Françoise Collin; Olivier Verola; Amelie Carbonnelle; Laure Vescovo; Binh Bui; Véronique Brouste; Hagay Sobol; Alain Aurias; Jean-Michel Coindre
Journal:  Genes Chromosomes Cancer       Date:  2010-06       Impact factor: 5.006

Review 4.  IgG4-related disease: nomenclature, clinical features, and treatment.

Authors:  John H Stone
Journal:  Semin Diagn Pathol       Date:  2012-11       Impact factor: 3.464

5.  Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.

Authors:  Danique L M van Broekhoven; Cornelis Verhoef; Dirk J Grünhagen; Joost M H H van Gorp; Michael A den Bakker; John W J Hinrichs; Carmen M A de Voijs; Thijs van Dalen
Journal:  Ann Surg Oncol       Date:  2014-10-24       Impact factor: 5.344

6.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

Review 7.  [Desmoid tumors in patients with familial adenomatous polyposis].

Authors:  A Pikaar; J W R Nortier; G Griffioen; H F A Vasen
Journal:  Ned Tijdschr Geneeskd       Date:  2002-07-20

8.  The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population.

Authors:  J J Reitamo; P Häyry; E Nykyri; E Saxén
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

9.  β-Catenin mutation status and outcomes in sporadic desmoid tumors.

Authors:  John T Mullen; Thomas F DeLaney; Andrew E Rosenberg; Long Le; A John Iafrate; Wendy Kobayashi; Jackie Szymonifka; Beow Y Yeap; Yen-Lin Chen; David C Harmon; Edwin Choy; Sam S Yoon; Kevin A Raskin; Francis J Hornicek; Gunnlauger P Nielsen
Journal:  Oncologist       Date:  2013-08-19

Review 10.  Desmoid tumors.

Authors:  J S Biermann
Journal:  Curr Treat Options Oncol       Date:  2000-08
View more
  4 in total

Review 1.  Adult desmoid tumors: biology, management and ongoing trials.

Authors:  Nicolas Penel; Frédéric Chibon; Sébastien Salas
Journal:  Curr Opin Oncol       Date:  2017-07       Impact factor: 3.645

2.  Frequent CTNNB1 p.S45 Mutations and Aggressive Clinical Behavior in Neuromuscular Choristoma-Associated Fibromatosis.

Authors:  Jodi M Carter; Andres A Maldonado; B Matthew Howe; Scott Okuno; Robert J Spinner
Journal:  Neurosurgery       Date:  2021-03-15       Impact factor: 4.654

3.  Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis.

Authors:  Kenji Tsuchihashi; Kyoko Yamaguchi; Ryosuke Taguchi; Kenichi Kohashi; Kayo Ijichi; Yuta Okumura; Michitaka Nakano; Akari Ohno; Tomonobu Hioki; Hozumi Shimokawa; Hiroshi Ariyama; Hitoshi Kusaba; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Case Rep Oncol       Date:  2022-02-07

4.  Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts.

Authors:  Keith M Skubitz; Paari Murugan; Christopher L Corless
Journal:  Cureus       Date:  2022-08-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.